Bright Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRIGHT, and what generic and branded alternatives to BRIGHT drugs are available?
BRIGHT has two approved drugs.
Drugs and US Patents for Bright
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brightgene | ENTECAVIR | entecavir | TABLET;ORAL | 212126-002 | Sep 25, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Brightgene | ENTECAVIR | entecavir | TABLET;ORAL | 212126-001 | Sep 25, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bright | FLUTICASONE PROPIONATE | fluticasone propionate | OINTMENT;TOPICAL | 215343-001 | Sep 1, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.